stockmarket

Kerrisdale Issues HubSpot Short Report, Calling Out Flawed, Expensive Products




By Sam Boughedda

Investing.com — In a short report issued Wednesday morning, investment research firm Kerrisdale Capital told investors that software developer HubSpot Inc ‘s (NYSE:) products are “flawed” and the “pricing is expensive.”

New York-based Kerrisdale pointed to HubSpot’s lack of profitability, fierce competition, and “stale products” as reasons it believes the company’s shares will soon fall.

Starting a series of Tweets outlining its reasons, Kerrsdale stated: “We’re short $HUBS. Report at http://kerr.co/hubs. Trading at 20x fwd rev, $HUBS benefited from a one-time COVID boost that lifted shares 6x. But fierce competition & stale products will lead to low growth / margins, long before the biz grows into its sky-high valuation.”

After closing Tuesday’s session at $680.20, HubSpot shares initially fell to a low of $654.53 following the report. Shares have since erased the majority of those losses and now trade around the $681 mark, marginally up for the day.

The company and its share price have soared since the start of the pandemic, climbing just under 70% in 2021 alone. In March 2020 its shares were priced at around $100. However, Kerrisdale said, “the COVID tailwind will fade and future growth will depend on expansion into already crowded markets.”

“Though HubSpot does have some devoted fans, its core technology – a database that can be used to create customized emails and web pages – is nothing special,” they added.

Kerrisdale’s views are in direct contrast to Goldman Sachs who initiated the company with a Buy rating earlier this month. Goldman analyst Gabriela Borges set a $953 price target on the stock, which at the time implied a 32% upside. In addition, in her research note, Borges said that HubSpot’s strategy and execution will drive further upside over the next 5 years after it proved its ability to expand beyond its marketing hub.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.